CXCL16 and Cognitive impairment: Piehl et al. found that in cerebrospinal fluid from patients with cognitive impairment, CXCL16 secretion increased, recruiting CD8+ T cells via CXCR6, which, upon activation, released granzyme and other effector molecules, exacerbating neuroinflammation and axonal damage [39].